Re‑Articulating the Strategic Value of HEOR Beyond ‘Supporting’ Clinical Evidence

1:30 pm - Thursday 29th October 2026

  • Re-articulating the strategic value of HEOR beyond ‘supporting’ clinical evidence
  • Demonstrating ROI when studies take 12–24 months but decisions demand speed
  • Building stronger advocacy and communication skills within HEOR leadership

Speakers:

Executive Director, Health Economics & Outcomes Research, Cardio-Renal-Metabolic
Boehringer Ingelheim